New approaches to high-throughput structure characterization of SH3 complexes: The example of Myosin-3 and Myosin-5 SH3 domains from S. cerevisiae

Protein Science

Volumn 15, Issue 4, 2006, Pages 795-807

  Musi, Valeria ^a   Birdsall, Berry ^a   Fernandez Ballester, Gregorio ^b   Guerrini, Remo ^c   Salvatori, Severo ^c   Serrano, Luis ^b   Pastore, Annalisa ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Myosin; NMR; Protein design; S. cerevisiae; Structure; Wilskott Aldrich syndrome

Indexed keywords

ACTIN; MYOSIN; MYOSIN III; PROTEIN SH3;

ACTIN POLYMERIZATION; AMINO ACID SEQUENCE; ARTICLE; HIGH THROUGHPUT SCREENING; MATHEMATICAL COMPUTING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY; WISKOTT ALDRICH SYNDROME;

BINDING SITES; COMPUTATIONAL BIOLOGY; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MYOSIN HEAVY CHAINS; MYOSIN TYPE I; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; SACCHAROMYCES CEREVISIAE PROTEINS; SRC HOMOLOGY DOMAINS;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 33645510752     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.051785506     Document Type: Article

References (58)

1. Anderson, B.L., Boldogh, I., Evangelista, M., Boone, C., Greene, L.A., and Pon, L.A. 1998. The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization. J. Cell Biol. 141: 1357-1370.
2. Arold, S., O'Brien, R., Franken, P., Strub, M.P., Hoh, F., Dumas, C., and Ladbury, J.E. 1998. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef. Biochemistry 37: 14683-14691.
3. Brannetti, B. and Helmer-Citterich, M. 2003. iSPOT: A web tool to infer the interaction specificity of families of protein modules. Nucleic Acids Res. 31: 3709-3711.
4. Brünger, A.T. 1993. XPLOR: A system for X-ray crystallography and NMR, version 3.1. Yale University Press, New Haven, CT.
5. Brünger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu, N.S., et al. 1998. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54: 905-921.
6. Cornilescu, G., Delaglio, F., and Bax, A. 1999. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13: 289-302.
7. Dalgarno, D.C., Botfield, M.C., and Rickles, R.J. 1997. SH3 domains and drug design: Ligands, structure, and biological function. Biopolymers 43: 383-400.
8. Derry, J.M., Kerns, J.A., Weinberg, K.I., Ochs, H.D., Volpini, V., Estivill, X., Walker, A.P., and Francke, U. 1995. WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Hum. Mol. Genet. 4: 1127-1135.
9. Dominguez, C., Boelens, R., and Bonvin, A.M. 2003. HADDOCK: A protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125: 1731-1737.
10. Eccles, C., Guntert, P., Billeter, M., and Wuthrich, K. 1991. Efficient analysis of protein 2D NMR spectra using the software package EASY. J. Biomol. NMR 1: 111-130.
11. Evangelista, M., Klebl, B.M., Tong, A.H., Webb, B.A., Leeuw, T., Leberer, E., Whiteway, M., Thomas, D.Y., and Boone, C. 2000. A role for myosin-I in actin assembly through interactions with Vrp1p, Bee1p, and the Arp2/3 complex. J. Cell Biol. 148: 353-362.
12. Feng, S., Chen, J.K., Yu, H., Simon, J.A., and Schreiber, S.L. 1994. Two binding orientations for peptides to the Src SH3 domain: Development of a general model for SH3-ligand interactions. Science 266: 1241-1247.
13. Fernandez-Ballester, G., Blanes-Mira, C., and Serrano, L. 2004. The tryptophan switch: Changing ligand-binding specificity from type-I to type-II in SH3 domains. J. Mol. Biol. 335: 619-629.
14. Folmer, R.H., Hilbers, C.W., Konings, R.N., and Nilges, M. 1997. Floating stereospecific assignment revisited: Application to an 18 kDa protein and comparison with J-coupling data. J. Biomol. NMR 3: 245-258.
15. Geli, M.I., Lombardi, R., Schmelzl, B., and Riezman, H. 2000. An intact SH3 domain is required for myosin I-induced actin polymerization. EMBO J. 19: 4281-4291.
16. Goodson, H.V., Anderson, B.L., Warrick, H.M., Pon, L.A., and Spudich, J.A. 1996. Synthetic lethality screen identifies a novel yeast myosin I gene (MYO5): Myosin I proteins are required for polarization of the actin cytoskeleton. J. Cell Biol. 133: 1277-1291.
17. Guerois, R., Nielsen, J.E., and Serrano, L. 2002. Predicting changes in the stability of proteins and protein complexes: A study of more than 1000 mutations. J. Mol. Biol. 320: 369-387.
18. Ikura, M. and Bax, A. 1992. Isotope-filtered 2D NMR of a protein-peptide complex: study of a skeletal muscle myosin light chain kinase fragment bound to calmodulin. J. Am. Chem. Soc. 114: 2433-2440.
19. Irving, J.A., Whisstock, J.C., and Lesk, A.M. 2001. Protein structural alignments and functional genomics. Proteins 42: 378-382.
20. Kainosho, M. 1997. Isotope labelling of macromolecules for structural determination (NMR supplement). Nat. Struct. Biol. 4: 858-861.
21. Kay, L.E., Torchia, D.A., and Bax, A. 1989. Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: Application to staphylococcal nuclease. Biochemistry 28: 8972-8979.
22. Kiel, C., Serrano, L., and Herrmann, C. 2004. A detailed thermodynamic analysis of Ras/effector complex interfaces. J. Mol. Biol. 340: 1039-1058.
23. Kiel, C., Wohlgemuth, S., Rousseau, F., Schymkowitz, J., Ferkinghoff-Borg, J., Wittinghofer, F., and Serrano, L. 2005. Recognizing and defining true Ras binding domains II: In silico prediction based on homology modelling and energy calculations. J. Mol. Biol. 348: 759-775.
24. Knapp, S., Mattson, P.T., Christova, P., Berndt, K.D., Karshikoff, A., Vihinen, M., Smith, C.I., and Ladenstein, R. 1998. Thermal unfolding of small proteins with SH3 domain folding pattern. Proteins 31: 309-319.
25. Lakowicz, J.R. 1999 Principles of fluorescence spectroscopy, 2nd ed. Kluwer Academic/Plenum, New York.
26. Linge, J.P., O'Donoghue, S.I., and Nilges, M. 2001. Automated assignment of ambiguous nuclear Overhauser effects with ARIA. Methods Enzymol. 339: 71-90.
27. Linge, J.P., Williams, M.A., Spronk, C.A., Bonvin, A.M., and Nilges, M. 2003. Refinement of protein structures in explicit solvent. Proteins 50: 496-506.
28. Linge, J.P., Habeck, M., Rieping, W., and Nilges, M. 2004. Correction of spin diffusion during iterative automated NOE assignment. J. Magn. Reson. 167: 334-342.
29. Lipari, G. and Szabo, A. 1982. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity. J. Am. Chem. Soc. 104: 4546-4559.
30. Maciejewski, M.W., Liu, D., Prasad, R., Wilson, S.H., and Mullen, G.P. 2000. Backbone dynamics and refined solution structure of the N-terminal domain of DNA polymerase b: Correlation with DNA binding and dRP lyase activity. J. Mol. Biol. 296: 229-253.
31. Martin, S.R. and Bayley, P.M. 2002. Regulatory implications of a novel mode of interaction of calmodulin with a double IQ-motif target sequence from murine dilute myosin V. Protein Sci. 11: 2909-2923.
32. Mayer, B.J. 2001. SH3 domains: Complexity in moderation. J. Cell Sci. 114: 1253-1263.
33. Mochida, J., Yamamoto, T., Fujimura-Kamada, K., and Tanaka, K. 2002. The novel adaptor protein, Mti1p, and Vrp1p, a homolog of Wiskott-Aldrich syndrome protein-interacting protein (WIP), may antagonistically regulate type-Imyosins in Saccharomyces cerevisiae. Genetics 160: 923-934.
34. Morton, C.J. and Campbell, I.D. 1994. SH3 domains: Molecular velcro. Curr. Biol. 4: 615-617.
35. Musacchio, A. 2002. How SH3 domains recognize proline. Adv. Protein Chem. 61: 211-268.
36. Musacchio, A., Saraste, M., and Wilmanns, M. 1994. High resolution crystal structure of tyrosine kinase SH3 domains complexed to proline-rich peptides. Nat. Struct. Biol. 1: 546-551.
37. Nguyen, J.T., Porter, M., Amoui, M., Miller, W.T., Zuckermann, R.N., and Lim, W.A. 2000. Improving SH3 domain ligand selectivity using a non-natural scaffold. Chem. Biol. 7: 463-473.
38. Nicastro, G., Margiocco, P., Cardinali, B., Stagnaro, P., Cauglia, F., Cuniberti, C., Collini, M., Thomas, D., Pastore, A., and Rocco, M. 2004. The role of unstructured extensions in the rotational diffusion properties of a globular protein: The example of the titin i27 module. Biophys. J. 87: 1227-1240.
39. Nilges, M. 1995. Calculation of protein structures with ambiguous distance restraints, automated assignment of ambiguous NOE crosspeaks and disulphide connectivities. J. Mol. Biol. 245: 645-660.
40. Nilges, M., Macias, M., O'Donoghue, S.I., and Oschkinat, H. 1997. Automated NOESY interpretation with ambiguous distance restraints: The refined NMR solution structure of the pleckstrin homology domain from β-spectrin. J. Mol. Biol. 269: 408-422.
41. Okishio, N., Nagai, M., Fukuda, R., Nagatomo, S., and Kitagawa, T. 2000. Interactions of phosphatidylinositol 3-kinase Src homology 3 domain with its ligand peptide studied by absorption, circular dichroism, and UV resonance raman spectroscopies. Biopolymers 57: 208-217.
42. Politou, A.S., Spadaccini, R., Joseph, C., Brannetti, B., Guerrini, R., Helmer-Citterich, M., Salvatori, S., Temussi, P.A., and Pastore, A. 2002. The SH3 domain of nebulin binds selectively to type-II peptides: Theoretical prediction and experimental validation. J. Mol. Biol. 316: 305-315.
43. Ren, R., Mayer, B.J., Cicchetti, P., and Baltimore, D. 1993. Identification of a 10-amino acid proline-rich SH3 binding site. Science 259: 1157-1161.
44. Rodal, A.A., Manning, A.L., Goode, B.L., and Drubin, D.G. 2003. Negative regulation of yeast WASP by two SH3 domain-containing proteins. Curr. Biol. 13: 1000-1008.
45. Schweimer, K., Hoffmann, S., Bauer, F., Friedrich, U., Kardinal, C., Feller, S.M., Biesinger, B., and Sticht, H. 2002. Structural investigation of the binding of a herpesviral protein to the SH3 domain of tyrosine kinase Lck. Biochemistry 41: 5120-5130.
46. Schymkowitz, J., Borg, J., Stricher, F., Nys, R., Rousseau, F., and Serrano, L. 2005. The FoldX Web server: An online force field. Nucleic Acids Res. 33: W382-W388.
47. Sippl, M.J. 1993. Recognition of errors in three dimensional structures of proteins. Proteins 17: 355-362.
48. Smithgall, T.E. 1995. SH2 and SH3 domains: Potential targets for anticancer drug design. J. Pharmacol. Toxicol. Methods 34: 125-132.
49. Sorimachi, H., Freiburg, A., Kolmerer, B., Ishiura, S., Stier, G., and Gregorio, C.C. 1997. Tissue-specific expression and α-actinin binding properties of the Z-disc titin: Implications for the vertebrate Z-discs. J. Mol. Biol. 270: 688-695.
50. Tong, A.H., Drees, B., Nardelli, G., Bader, G.D., Brannetti, B., Castagnoli, L., Evangelista, M., Ferracuti, S., Nelson, B., Paoluzi, S., et al. 2002. A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules. Science 295: 321-324.
51. Vidal, M., Gigoux, V., and Garbay, C. 2001. SH2 and SH3 domains as targets for anti-proliferative agents. Crit. Rev. Oncol. Hematol. 40: 175-186.
52. Viguera, A.R., Arrendo, J.L., Musacchio, A., Saraste, M., and Serrano, L. 1994. Characterization of the interaction of natural proline-rich peptides with five different SH3 domains. Biochemistry 33: 10925-10933.
53. Vriend, G. 1990. WHAT IF: A molecular modeling and drug design program. J. Mol. Graph. 8: 51-55.
54. Vuilleumier, S., Sancho, J., Loewenthal, R., and Fersht, A.R. 1993. Circular dichroism studies of barnase and its mutants: Characterization of the contribution of aromatic side chains. Biochemistry 32: 10303-10313.
55. Woody, R.W. 1995. Circular dichroism. Methods Enzymol. 246: 34-71.
56. Yu, H., Rosen, M.K., Shin, T.B., Seidel-Dugan, C., Brugge, J.S., and Schreiber, S.L. 1992. Solution structure of the SH3 domain of Src and identification of its ligand-binding site. Science 258: 1665-1668.
57. Yu, H., Chen, J.K., Feng, S., Dalgarno, D.C., Brauer, A.W., and Schreiber, S.L. 1994. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76: 933-945.
58. Xenarios, I. and Eisenberg, D. 2001. Protein interaction databases. Curr. Opin. Biotechnol. 12: 334-339.